Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Novo Nordisk has filed applications for approval in Europe of its ultra long-acting insulin Degludec and insulin combination analogue DegludecPlus.
http://www.pharmatimes.com/Article/...lin_drugs_to_rival_Sanofi_s_Lantus_in_EU.aspx
http://www.pharmatimes.com/Article/...lin_drugs_to_rival_Sanofi_s_Lantus_in_EU.aspx